Our team of executives, pharmaceutical developers and scientists thrive when tackling big problems from new angles. We have a strong track record of clinical trial success in chronic autoimmune diseases, and we are expanding our pipeline into acute inflammatory diseases to provide new and potentially better treatment options for patients. We are a versatile team that is focused on pursuing new approaches to solve long-standing problems, to provide new treatment options for patients.